Home › Ulcerative Colitis › Missouri › Kansas City

Ulcerative Colitis clinical trials in Kansas City, MO

4 studies for Ulcerative Colitis are looking for participants at sites in and around Kansas City (within about 30 miles). Open a study to see who can join and how to contact the study team.

A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

RecruitingPhase 4

Mid America Gastro Intestinal Consultants, Kansas City

Ages 18 to 80 · All sexes · Updated Sep 30, 2026 · NCT06581328

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

RecruitingPhase 1

University Health Truman Medical Center, Kansas City
University of Kansas Cancer Center - North, Kansas City
University of Kansas Cancer Center at North Kansas City Hospital, North Kansas City · 2 mi away
and 1 more

Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT03816345

A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)

RecruitingPhase 4

Mid-America Gastro-Intestinal Consultants, Kansas City

Ages 18 to 65 · All sexes · Updated Sep 21, 2026 · NCT06095128

A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

RecruitingPhase 2

Mirador Therapeutics Selected Site, Kansas City

Ages 18 to 80 · All sexes · Updated Mar 12, 2026 · NCT07113522

About Ulcerative Colitis

Ulcerative Colitis (UC) can cause long-lasting swelling and ulcers in the large intestine. It is a type of inflammatory bowel disease. Find out more.

More about Ulcerative Colitis on MedlinePlus

Ulcerative Colitis trials in other cities

Other studies in Kansas City

From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.